TABLE 2.
Clinical parameters of the sampling sites at the baseline and 1-month examinations
| Parametera | Results at baseline | Results at 1 mo |
|---|---|---|
| PPD (mm) | ||
| STFX | 5.9 ± 0.8 | 5.1 ± 0.7b |
| AZM | 6.2 ± 1.1 | 4.9 ± 1.3b |
| CAL (mm) | ||
| STFX | 7.0 ± 1.3 | 6.3 ± 1.3b |
| AZM | 6.9 ± 1.5 | 5.8 ± 1.8b |
| BOP | ||
| STFX | 50/50 | 26/50 |
| AZM | 50/50 | 17/50 |
| Plaque | ||
| STFX | 19/50 | 16/50 |
| AZM | 14/50 | 10/50 |
a
PPD, probing pocket depth; CAL, clinical attachment level; BOP, bleeding on probing; plaque, dental plaque; STFX, sitafloxacin; AZM, azithromycin. PPD and CAL are expressed as means ± SD. BOP and plaque are expressed as the number of positive sites/all examined sites.
b
P < 0.05 versus baseline (paired t test).